| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 09/14/2000 | WO2000053034A1 Active oxygen annihilating agent |
| 09/14/2000 | WO2000030425A3 Method of using pon-1 to decrease atheroma formation |
| 09/14/2000 | WO2000025812A3 Method for preparing solid phase conjugate vaccines |
| 09/13/2000 | EP1033981A1 Formulations and methods for reducing toxicity of antineoplastic agents |
| 09/13/2000 | EP0764166B1 Corticotropin releasing factor antagonists |
| 09/12/2000 | US6117365 N-(3,4-dihydroxybenzyl)-3,5-dimethoxy-4-hydroxy-e-cinnamide, for example; use as antioxidants or as free-radical scavengers, in particular in the cosmetic or dermatological fields, and in foods |
| 09/08/2000 | WO2000052013A2 Thiazoloindolinone compounds |
| 09/08/2000 | CA2361580A1 Thiazoloindolinone compounds |
| 09/06/2000 | EP1032413A1 Chemoprotective bacterial strains |
| 09/06/2000 | CN1265647A Acrylic metalloprotease inhibitor |
| 09/05/2000 | US6114504 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins |
| 09/05/2000 | US6114347 Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors |
| 09/05/2000 | US6113951 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins |
| 08/31/2000 | WO2000050039A1 Agent for use in transplantation |
| 08/31/2000 | WO2000050019A2 USE OF R-ARYL PROPIONIC ACIDS FOR PRODUCING MEDICAMENTS TO TREAT DISEASES IN HUMANS AND ANIMALS, WHEREBY SAID DISEASES CAN BE THERAPEUTICALLY INFLUENCED BY INHIBITING THE ACTIVATION OF NF-λB |
| 08/30/2000 | CN1264599A Application of coenzyme NAD and its composition in cell-protecting medicines |
| 08/30/2000 | CN1264583A Active aloe powder and preparing process thereof |
| 08/29/2000 | US6110940 Salts of an anti-migraine indole derivative |
| 08/24/2000 | WO2000013654A3 A carotenoid composition containing phytoene and phytofluene |
| 08/23/2000 | EP1028626A1 Method for the augmentation of gene expression |
| 08/22/2000 | US6107315 Nervous system disorders |
| 08/22/2000 | US6107282 Treatment of C. difficile toxin B associated conditions |
| 08/22/2000 | CA2187409C Stable crystalline tetrahydrofolic acid salts |
| 08/16/2000 | EP1027893A2 Alginate containing medicament and implant for treating fibrosis |
| 08/16/2000 | EP1027053A1 Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus |
| 08/16/2000 | CN1263471A Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing antitumor agent and hydroxamic acid derivative |
| 08/16/2000 | CN1263469A Pharmaceutical compositions of peptides having low solubility in physiological medium |
| 08/15/2000 | US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent |
| 08/15/2000 | US6103247 Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetics and/or dermatological field and processes employing it |
| 08/15/2000 | CA2148671C Stable crystalline (6s)-and (6r)-tetrahydrofolic acid |
| 08/11/2000 | WO2000047225A2 Tuberculosis vaccine formulation comprising monoglycerides or fatty acids as adjuvant |
| 08/10/2000 | WO2000045791A2 Method for controlling liposome size |
| 08/10/2000 | WO2000045769A2 Process for extracting polyphenolic antioxidants from purine-containing plants |
| 08/10/2000 | WO2000045634A1 Inositol derivatives for inhibiting superoxide anion production |
| 08/10/2000 | WO2000026399A3 Method for the production of quercetin and isoquercetin derivatives |
| 08/10/2000 | WO2000010588A9 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 08/10/2000 | CA2361551A1 Method for controlling liposome size |
| 08/10/2000 | CA2361531A1 Process for extracting polyphenolic antioxidants from purine-containing plants |
| 08/10/2000 | CA2361066A1 Inositol derivatives for inhibiting superoxide anion production |
| 08/09/2000 | EP1026164A1 Process for extracting polyphenolic antioxidants from purine-containing plants |
| 08/09/2000 | EP1024834A2 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 08/09/2000 | EP1024830A1 Antigen vectors in the form of multilamellar vesicles |
| 08/09/2000 | EP1006964A4 Intrauterine chemical necrosing method, composition, and apparatus |
| 08/09/2000 | CN1262690A Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of same |
| 08/08/2000 | US6099845 Process for the preparation of Rhus verniciflua extract and anti-cancer composition containing same |
| 08/08/2000 | US6099837 Pharmaceutical preparation for treating blood coagulation disorders |
| 08/03/2000 | WO2000044375A1 Antioxidant compositions and methods for companion animals |
| 08/03/2000 | WO2000028947A3 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 08/02/2000 | EP1023040A1 Compositions based on plant extracts |
| 08/02/2000 | CN1055005C Ginseng and astragalus root powder for curing lead absorption of children and preparing method |
| 08/01/2000 | US6096359 Polyphenol fractions of tea, the use thereof and formulations containing them |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043395A1 Substituted porphyrins |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/26/2000 | CN1261367A Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 07/25/2000 | US6093704 Use of dopamine receptor antagonists in palliative tumor therapy |
| 07/20/2000 | WO2000041705A1 Pre-conditioning against cell death |
| 07/20/2000 | CA2360268A1 Pre-conditioning against cell death |
| 07/19/2000 | EP1020180A2 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 07/19/2000 | EP1019067A1 Methods of using emu oil and active fractions thereof as an insect repellent |
| 07/19/2000 | EP1019023A1 Stabilized preparations for use in nebulizers |
| 07/19/2000 | EP1019022A1 Perforated microparticles and methods of use |
| 07/19/2000 | EP1019021A1 Stabilized preparations for use in metered dose inhalers |
| 07/19/2000 | EP1019020A1 Stabilized bioactive preparations and methods of use |
| 07/19/2000 | EP0760819B1 Tricyclic dicarbonyl derivatives |
| 07/19/2000 | CN1054506C Pharmaceutical composition use |
| 07/18/2000 | US6090842 Reduces concentration of oxygen in cells |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/13/2000 | WO2000040241A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 07/13/2000 | CA2358851A1 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 07/12/2000 | EP1018008A2 Method of identification of leads or active compounds |
| 07/06/2000 | WO2000039104A1 Phenazine compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000038647A1 Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis |
| 07/05/2000 | EP1015006A2 Cocoa extract compounds and methods for making and using the same |
| 07/05/2000 | EP1014804A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/04/2000 | US6083988 Azulenyl nitrone spin trapping agents, methods of making and using same |
| 07/04/2000 | US6083930 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 06/29/2000 | WO2000037108A1 Oil-in-water emulsion exhibiting a protective action against damages to human organs resulting from peroxidation, and the production and use thereof |
| 06/29/2000 | WO2000002543A3 Antihypersensitive combination of valsartan and calcium channel blocker |
| 06/29/2000 | DE19859045A1 Emulsion vom Typ Öl in Wasser mit Schutzwirkung gegen Peroxidationsschäden an menschlichen Organen, deren Herstellung und Verwendung Emulsion of oil in water with a protective effect against peroxidation of human organs, their preparation and use |
| 06/28/2000 | EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same |
| 06/28/2000 | EP1012296A2 Mammalian thioredoxin |
| 06/28/2000 | EP1011440A1 Vaccine against lipopolysaccharide core |
| 06/27/2000 | US6080785 Reacting a alkylnedi-primary amine compound with a protective group such as trifluoroacetyl or benzyl group reagent to form an intermediate, reacting the intermediate with haloacetic tert-bytyl ester to form ester groups, deprotecting |
| 06/22/2000 | WO2000035948A1 Methods and compositions for treating disorders involving excitotoxicity |
| 06/22/2000 | CA2352570A1 Methods and compositions for treating disorders involving excitotoxicity |
| 06/21/2000 | EP1010698A1 1,2-dithiolane derivatives, their process of preparation and pharmaceutical compositions containing them |
| 06/21/2000 | EP1009738A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 06/21/2000 | EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 06/21/2000 | EP1009730A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 06/21/2000 | EP1009418A1 Robinia pseudoacacia lectin and its uses |
| 06/21/2000 | CN1257510A New BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 06/21/2000 | CN1257072A Novel 1,2-amylic cycle disulfide, its preparation process and medicinal compoisitions containing same |
| 06/21/2000 | CN1256877A Arctium lappa tea |
| 06/20/2000 | CA2013381C Selective adenosine receptor compounds |
| 06/15/2000 | DE19854628A1 Use of plant parts or extracts of Anacardiaceae for treatment or prevention of tumor diseases and as a prophylactic compound for the effects of gene toxins |
| 06/14/2000 | EP1006964A1 Intrauterine chemical necrosing method, composition, and apparatus |
| 06/14/2000 | CN1256628A Sustained-release compositions and method for preparing same |
| 06/08/2000 | WO2000032805A1 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases |
| 06/08/2000 | WO2000032162A1 Use of plant extracts with an anti-radical-type action |